Research

Researchers Develop Marburg Virus Treatment Effective Five Days After Infection

Virus causes hemorrhagic fever often leading to death


By Donna Ramirez | April 07, 2017

An antibody treatment successfully protected nonhuman primates against the deadly Marburg and Ravn viruses even when given five days after becoming infected, according to the latest findings of a collaborative team from The University of Texas Medical Branch at Galveston, Mapp Biopharmaceutical Inc., and Vanderbilt University. The findings are now available in Science Translational Medicine.

There are currently no vaccines or drugs approved for human use to protect against the Marburg and Ravn viruses. These two filoviruses, which are in the same virus family as Ebola, cause severe and often lethal disease in people. The average case fatality rate of Marburg virus disease since the first recognized outbreak in 1967 is 80 percent.

Monoclonal antibodies are a technology that is currently in wide use for treating autoimmune diseases and cancers. There are more than 45 monoclonal antibodies approved by the U.S. Food and Drug Administration and European Medicines Agency.

“In this paper, we demonstrated that one monoclonal antibody is able to protect up to 100 percent of Marburg or Ravn virus-infected non-human primates when the antibody treatment is given up to five days following exposure to a lethal amount of the virus,” said UTMB’s Thomas Geisbert, professor in the department of microbiology and immunology. “These findings extend the growing body of evidence that monoclonal antibodies can provide protection during advanced stages of disease with highly dangerous viruses and could be useful during an epidemic.”

The study was conducted in Biosafety Level (BSL)-4 at UTMB’s Galveston National Laboratory. BSL-4 is a highly-restricted area where scientists wear positive pressure protective suits and study pathogens that cause severe and often fatal diseases. UTMB has the only functioning BSL-4 laboratory located on an American university campus.

The 2013 to 2016 Ebola virus epidemic highlighted the troubling lack of preventive or treatment options for filoviruses. Some of the therapeutics used to treat those infected with Ebola were developed and tested in the GNL.

“The level of protection observed by Dr. Geisbert’s team with this antibody is very impressive. We plan to advance this product towards human safety testing as quickly as possible,” said Larry Zeitlin, president of Mapp Biopharmaceutical Inc.

Other authors of this paper include UTMB’s Chad Mire, Joan Geisbert, Viktoriya Borisevich, Karla Fenton, Krystle Agans and Daniel Deer; Andrew Flyak and James Crowe, Jr. from Vanderbilt University Medical Center; Herta Steinkellner from the University of Natural Resources and Life Sciences in Vienna and Ognian Bohorov, Natasha Bohorova, Charles Goodman, Andrew Hiatt, Do Kim, Michael Pauly, Jesus Velasco and Kevin Whaley.

This study was supported by the Department of Health and Human Services, National Institutes of Health and BSL-4 operations support of the Galveston National Laboratory.

Tags | Research



Social Posts

profile_image

Texas Children's

@TexasChildrens

A3 Other possible signs can include decreased fetal movements or bleeding or spotting that may warrant additional screening#Microcephaly101

9 mins ago
profile_image

Texas Children's

@TexasChildrens

A3 Symptoms of microcephaly & the associated viral infections can be mild in the mother. #Microcephaly101

10 mins ago
profile_image

Texas Children's

@TexasChildrens

A3 There can be symptoms for the associated viral infections such as rash, vomiting, muscle aches and fever. #Microcephaly101

10 mins ago
profile_image

TAMU Health Sciences

@TAMHSC

What is normal, and what is too much #anxiety? https://t.co/WUA1AvNgUJ #TAMHSC #Health https://t.co/DxG2cuUuxA

16 mins ago
profile_image

MD Anderson

@MDAndersonNews

#Clinicaltrial to study the benefits of exercise regime prior to #pancreaticcancer treatment? https://t.co/zEYJA4tP26

24 mins ago
profile_image

Baylor College of Medicine

BaylorCollegeOfMedicine

Congratulations to our academic partner Texas Children's Hospital, ranked among the best hospitals in the country!

27 mins ago
profile_image

San José Clinic

SanJoseClinic

It's #insuranceawarenessday & we hope you won't forget that there are still thosands who can't access insurance. We've been serving this vulnerable population f...

32 mins ago
profile_image

Veterans Affairs

@DeptVetAffairs

VA to open emergency rooms to 'bad paper' Veterans on July 5 https://t.co/UAVLTtvLi0 via @MilitaryTimes

59 mins ago
profile_image

BCMHouston

@bcmhouston

RT @jmcdeavitt: Houston one of world's 10 happiest travel destinations per @CNTraveler. @bcmhouston no doubt impacted "joy index" https://t?

1 hour ago
profile_image

Rice University

@RiceUniversity

https://t.co/d5xFkQyNT3

1 hour ago
profile_image

UniversityofHouston

@UHouston

@macyleanne5678 @UofHClassOf2021 Say hello to the Queen for us! ??

1 hour ago
profile_image

MD Anderson Cancer Center

MDAnderson

“When Dr. Kadia gave me his advice to stop running, I took it because I’d established this scientific rapport with him. I did everything that he suggested to th...

2 hours ago
profile_image

Pepon Calderón

aquí seguimos ahora ya confirmado le volvió la bacteria a la guera y estaremos por 2 o 3 días mas

2 hours ago
profile_image

UTMB Health

@utmbhealth

Avoid excessive summer weight gain. Keep your kid's diet on track this summer with these five nutrition strategies. https://t.co/T3ihVVpIXK

2 hours ago
profile_image

UTMB Health

UTMB.edu

Researchers at the The University of Texas at Austin found that kids are more likely to become overweight or obese during the summer break when weight gain occu...

2 hours ago